Denali Therapeutics Inc. Capital Expenditures Incurred but Not yet Paid
Denali Therapeutics Inc. (DNLI) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-02-26
- Denali Therapeutics Inc. capital expenditures incurred but not yet paid for the quarter ending 2025-03-31 was $488.00K, a 74.94% decline year-over-year.
- Denali Therapeutics Inc. capital expenditures incurred but not yet paid for the quarter ending 2024-12-31 was $929.00K.
- Denali Therapeutics Inc. capital expenditures incurred but not yet paid for the quarter ending 2024-09-30 was $35.00K, a 99.38% decline year-over-year.
- Denali Therapeutics Inc. capital expenditures incurred but not yet paid for the quarter ending 2024-06-30 was -$1.72M.
- Denali Therapeutics Inc. capital expenditures incurred but not yet paid for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Denali Therapeutics Inc. capital expenditures incurred but not yet paid for fiscal 2024 was $1.19M, a 115.55% increase from fiscal 2023.
- Denali Therapeutics Inc. capital expenditures incurred but not yet paid for fiscal 2023 was $553.00K, a 62.23% decline from fiscal 2022.
- Denali Therapeutics Inc. capital expenditures incurred but not yet paid for fiscal 2022 was $1.46M, a 146.88% increase from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-26 | |||
| 2025-03-31 | $488.00K 10-Q · filed 2025-05-06 | $1.42M derived: sum of 2 quarters · filed 2026-02-26 | $1.45M derived: sum of 3 quarters · filed 2026-02-26 | -$267.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-12-31 | $929.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $964.00K derived: sum of 2 quarters · filed 2026-02-26 | -$755.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.19M 10-K · filed 2026-02-26 |
| 2024-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$1.68M derived: sum of 2 quarters · filed 2024-11-06 | $263.00K 10-Q · filed 2024-11-06 | -$5.41M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $228.00K 10-Q · filed 2024-08-01 | -$5.45M derived: sum of 3 quarters · filed 2026-02-26 | $206.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $1.95M 10-Q · filed 2025-05-06 | -$3.73M derived: sum of 2 quarters · filed 2026-02-26 | $1.93M derived: sum of 3 quarters · filed 2026-02-26 | -$3.58M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$5.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$22.00K derived: sum of 2 quarters · filed 2026-02-26 | -$5.52M derived: sum of 3 quarters · filed 2026-02-26 | $553.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $5.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $155.00K derived: sum of 2 quarters · filed 2024-11-06 | $6.23M 10-Q · filed 2024-11-06 | $7.41M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$5.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $575.00K 10-Q · filed 2024-08-01 | $1.75M derived: sum of 3 quarters · filed 2025-02-27 | $1.72M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $6.08M 10-Q · filed 2024-05-07 | $7.25M derived: sum of 2 quarters · filed 2025-02-27 | $7.22M derived: sum of 3 quarters · filed 2025-02-27 | $7.42M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.14M derived: sum of 2 quarters · filed 2025-02-27 | $1.35M derived: sum of 3 quarters · filed 2025-02-27 | $1.46M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $170.00K derived: sum of 2 quarters · filed 2023-11-07 | $284.00K 10-Q · filed 2023-11-07 | $848.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $207.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $321.00K 10-Q · filed 2023-08-08 | $885.00K derived: sum of 3 quarters · filed 2024-02-28 | $685.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $114.00K 10-Q · filed 2023-05-08 | $678.00K derived: sum of 2 quarters · filed 2024-02-28 | $478.00K derived: sum of 3 quarters · filed 2024-02-28 | $707.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $564.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $364.00K derived: sum of 2 quarters · filed 2024-02-28 | $593.00K derived: sum of 3 quarters · filed 2024-02-28 | $593.00K 10-K · filed 2024-02-28 |
| 2021-09-30 | -$200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $29.00K derived: sum of 2 quarters · filed 2022-11-03 | $29.00K 10-Q · filed 2022-11-03 | $64.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $229.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $229.00K 10-Q · filed 2022-08-08 | $264.00K derived: sum of 3 quarters · filed 2023-02-27 | $294.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | $35.00K derived: sum of 2 quarters · filed 2023-02-27 | $65.00K derived: sum of 3 quarters · filed 2023-02-27 | $67.00K derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $65.00K derived: sum of 2 quarters · filed 2023-02-27 | $67.00K derived: sum of 3 quarters · filed 2023-02-27 | $67.00K 10-K · filed 2023-02-27 |
| 2020-09-30 | $30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $32.00K derived: sum of 2 quarters · filed 2021-11-04 | $32.00K 10-Q · filed 2021-11-04 | -$1.47M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $2.00K 10-Q · filed 2021-08-04 | -$1.50M derived: sum of 3 quarters · filed 2022-02-28 | -$2.16M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-07 | -$1.50M derived: sum of 2 quarters · filed 2022-02-28 | -$2.16M derived: sum of 3 quarters · filed 2022-02-28 | -$1.57M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$2.16M derived: sum of 2 quarters · filed 2022-02-28 | -$1.57M derived: sum of 3 quarters · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 |
| 2019-09-30 | -$662.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$69.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.50M 10-Q · filed 2020-11-05 | $1.80M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $593.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $2.16M 10-Q · filed 2020-08-07 | $2.46M derived: sum of 3 quarters · filed 2021-02-26 | $2.50M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $1.57M 10-Q · filed 2020-05-07 | $1.87M derived: sum of 2 quarters · filed 2021-02-26 | $1.90M derived: sum of 3 quarters · filed 2021-02-26 | $1.66M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $298.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $335.00K derived: sum of 2 quarters · filed 2021-02-26 | $89.00K derived: sum of 3 quarters · filed 2021-02-26 | $335.00K 10-K · filed 2021-02-26 |
| 2018-09-30 | $37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$209.00K derived: sum of 2 quarters · filed 2019-11-06 | $37.00K 10-Q · filed 2019-11-06 | $62.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | -$246.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $0.00 10-Q · filed 2019-08-06 | $25.00K derived: sum of 3 quarters · filed 2020-02-27 | |
| 2018-03-31 | $246.00K 10-Q · filed 2019-05-08 | $271.00K derived: sum of 2 quarters · filed 2020-02-27 | ||
| 2017-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $103.00K 10-K · filed 2020-02-27 | ||
| 2017-09-30 | $78.00K 10-Q · filed 2018-11-08 | |||
| 2017-03-31 | $98.00K 10-Q · filed 2018-05-11 | |||
| 2016-12-31 | $233.00K 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |